Intravenous immunoglobulins modulate neutrophil activation and vascular injury through FcγRIII and SHP-1.
about
Precipitating factors and targeted therapies in combating the perils of sickle cell disease--- A special nutritional considerationIntravenous immunoglobulin (IVIg) provides protection against endothelial cell dysfunction and death in ischemic stroke.Of ITIMs, ITAMs, and ITAMis: revisiting immunoglobulin Fc receptor signaling.Identification of new therapeutic targets by genome-wide analysis of gene expression in the ipsilateral cortex of aged rats after stroke.Single-dose intravenous gammaglobulin can stabilize neutrophil Mac-1 activation in sickle cell pain crisis.Endocytosis of soluble immune complexes leads to their clearance by FcγRIIIB but induces neutrophil extracellular traps via FcγRIIA in vivo.ADAM17 cleaves CD16b (FcγRIIIb) in human neutrophilsNeutrophils, platelets, and inflammatory pathways at the nexus of sickle cell disease pathophysiology.Beyond hydroxyurea: new and old drugs in the pipeline for sickle cell disease.Antibodies and their receptors: different potential roles in mucosal defense.Brief Report: HIV-1 Infection Impairs CD16 and CD35 Mediated Opsonophagocytosis of Mycobacterium tuberculosis by Human Neutrophils.Vaso-occlusion in sickle cell disease: pathophysiology and novel targeted therapies.The multifaceted functions of neutrophils.IVIG-mediated effector functions in autoimmune and inflammatory diseases.Developing new pharmacotherapeutic approaches to treating sickle-cell disease.
P2860
Q26742061-C56D137D-38A2-4546-BEF9-C8839CACD5F3Q33836525-CF568BAD-AC8C-4E15-BD4B-003E9E425E0CQ34499276-C2BF706F-8ACD-4A9B-8EB1-4C286DF2629DQ34516000-EF35DD13-A36A-481B-8041-FE415833F0F2Q35537053-D8D58A81-6279-4616-8235-B249D974D236Q36425452-6C0ACDF1-C77D-40A5-B7EB-C40DB0212FD3Q36565321-AA5E7126-29A4-4639-961B-BF9C078E17D3Q36596850-55430B70-6286-4636-B386-CE62B44F5F28Q36596855-48F92CE9-BB57-4A08-B212-2EE41F1686ECQ37015487-177BE51B-B49B-4E60-9223-5A2EEF268BDFQ37246262-24421573-3F17-4996-B1DC-7F6533DA6D30Q37370659-E70F289F-C989-405C-A34D-E475C638E09BQ38139589-CE1174BA-D3D8-4374-944D-3FADF5149BC1Q38699812-D673A037-215B-4355-84B1-F9A9BC923D2DQ50207951-BBB24432-41F5-4CEA-AE61-D59E8B050CA1
P2860
Intravenous immunoglobulins modulate neutrophil activation and vascular injury through FcγRIII and SHP-1.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Intravenous immunoglobulins mo ...... ury through FcγRIII and SHP-1.
@ast
Intravenous immunoglobulins mo ...... ury through FcγRIII and SHP-1.
@en
type
label
Intravenous immunoglobulins mo ...... ury through FcγRIII and SHP-1.
@ast
Intravenous immunoglobulins mo ...... ury through FcγRIII and SHP-1.
@en
prefLabel
Intravenous immunoglobulins mo ...... ury through FcγRIII and SHP-1.
@ast
Intravenous immunoglobulins mo ...... ury through FcγRIII and SHP-1.
@en
P2093
P2860
P1433
P1476
Intravenous immunoglobulins mo ...... ury through FcγRIII and SHP-1.
@en
P2093
Andrés Hidalgo
Jung-Eun Jang
Paul S Frenette
P2860
P304
P356
10.1161/CIRCRESAHA.112.266411
P577
2012-03-13T00:00:00Z